help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roesch, D. M.
Right arrow Articles by Sandberg, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roesch, D. M.
Right arrow Articles by Sandberg, K.
Endocrinology Vol. 141, No. 12 4629-4636
Copyright © 2000 by The Endocrine Society

ARTICLES

Estradiol Attenuates Angiotensin-Induced Aldosterone Secretion in Ovariectomized Rats1

Darren M. Roesch2, Ying Tian, Wei Zheng, Min Shi, Joseph G. Verbalis and Kathryn Sandberg

Divisions of Endocrinology and Metabolism and Nephrology and Hypertension, Department of Medicine, Georgetown University, Washington, D.C. 20007

Address all correspondence and requests for reprints to: Dr. Darren M. Roesch, 350 Building D, 4000 Reservoir Road NW, Washington, D.C. 20007. E-mail: roeschd{at}gunet.georgetown.edu

Estrogen replacement therapy significantly reduces the risk of cardiovascular disease in postmenopausal women. Previous studies indicate that estradiol (E2) decreases angiotensin II (AT) receptor density in the adrenal and pituitary in NaCl-loaded rats. We used an in vivo model that eliminates the potentially confounding influence of ACTH to determine whether the E2-induced decrease in adrenal AT receptor expression affects aldosterone responses to angiotensin II (Ang II). Female rats were ovariectomized, treated with oil (OVX) or E2 (OVX+E2; 10 µg, sc) for 14 days, and fed a NaCl-deficient diet for the last 7 days to maximize adrenal AT receptor expression and responsiveness. On days 12–14 rats were treated with dexamethasone (DEX; 25 µg, ip, every 12 h) to suppress plasma ACTH. On day 14 aldosterone secretion was measured after a 30-min infusion of Ang II (330 ng/min). Ang II infusion increased the peak plasma aldosterone levels to a lesser degree in the OVX+E2 than in the OVX rats (OVX, 1870 ± 290 pg/ml; OVX+E2, 1010 ± 86 pg/ml; P < 0.05). Ang II-induced ACTH and aldosterone secretion was also studied in rats that were not treated with DEX. In the absence of DEX, the peak plasma aldosterone response was also significantly decreased (OVX, 5360 ± 1200 pg/ml; OVX+E2, 2960 ± 570 pg/ml; P < 0.05). However, E2 also reduced the plasma ACTH response to Ang II (P < 0.05; OVX, 220 ± 29 pg/ml; OVX+E2, 160 ± 20 pg/ml), suggesting that reduced pituitary ACTH responsiveness to Ang II contributes to the effect of E2 on Ang II-induced aldosterone secretion. Adrenal AT1 binding studies confirmed that E2 significantly reduces adrenal AT1 receptor expression in both the presence and absence of DEX in NaCl-deprived rats. These results indicate that E2-induced decreases in pituitary and adrenal AT1 receptor expression are associated with attenuated pituitary ACTH and adrenal aldosterone responses to Ang II and suggest that estrogen replacement therapy may modulate Ang II-stimulated aldosterone secretion as part of its well known cardioprotective actions.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. C. Sullivan
Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1220 - R1226.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. S. Rigsby, A. E. Burch, S. Ogbi, D. M. Pollock, and A. M. Dorrance
Intact female stroke-prone hypertensive rats lack responsiveness to mineralocorticoid receptor antagonists
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1754 - R1763.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
N. B. Ojeda, D. Grigore, E. B. Robertson, and B. T. Alexander
Estrogen Protects Against Increased Blood Pressure in Postpubertal Female Growth Restricted Offspring
Hypertension, October 1, 2007; 50(4): 679 - 685.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
H. Ji, W. Zheng, C. Falconetti, D. M. Roesch, S. E. Mulroney, and K. Sandberg
17beta-Estradiol deficiency reduces potassium excretion in an angiotensin type 1 receptor-dependent manner
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H17 - H22.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. L. Rogers, A. R. Mitchell, C. Maric, K. Sandberg, A. Myers, and S. E. Mulroney
Effect of sex hormones on renal estrogen and angiotensin type 1 receptors in female and male rats
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R794 - R799.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. C. Chappell, L. M. Yamaleyeva, and B. M. Westwood
Estrogen and salt sensitivity in the female mRen(2).Lewis rat
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1557 - R1563.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. A. Dean, J. Tan, E. R. O'Brien, and F. H. H. Leenen
17{beta}-Estradiol downregulates tissue angiotensin-converting enzyme and ANG II type 1 receptor in female rats
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2005; 288(3): R759 - R766.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
H. Ji, S. Menini, K. Mok, W. Zheng, C. Pesce, J. Kim, S. Mulroney, and K. Sandberg
Gonadal steroid regulation of renal injury in renal wrap hypertension
Am J Physiol Renal Physiol, March 1, 2005; 288(3): F513 - F520.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
P. J. Harvey, B. L. Morris, J. A. Miller, and J. S. Floras
Estradiol Induces Discordant Angiotensin and Blood Pressure Responses to Orthostasis in Healthy Postmenopausal Women
Hypertension, March 1, 2005; 45(3): 399 - 405.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
C. Hinojosa-Laborde, T. Craig, W. Zheng, H. Ji, J. R. Haywood, and K. Sandberg
Ovariectomy Augments Hypertension in Aging Female Dahl Salt-Sensitive Rats
Hypertension, October 1, 2004; 44(4): 405 - 409.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. B. Ahmed, A. K. Kang, K. D. Burns, C. R. J. Kennedy, V. Lai, D. C. Cattran, J. W. Scholey, and J. A. Miller
Effects of Oral Contraceptive Use on the Renal and Systemic Vascular Response to Angiotensin II Infusion
J. Am. Soc. Nephrol., March 1, 2004; 15(3): 780 - 786.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
T. K. Owonikoko, M. E. Fabucci, P. R. Brown, N. Nisar, J. Hilton, W. B. Mathews, H. T. Ravert, P. Rauseo, K. Sandberg, R. F. Dannals, et al.
In Vivo Investigation of Estrogen Regulation of Adrenal and Renal Angiotensin (AT1) Receptor Expression by PET
J. Nucl. Med., January 1, 2004; 45(1): 94 - 100.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. C. Chappell, P. E. Gallagher, D. B. Averill, C. M. Ferrario, and K. B. Brosnihan
Estrogen or the AT1 Antagonist Olmesartan Reverses the Development of Profound Hypertension in the Congenic mRen2.Lewis Rat
Hypertension, October 1, 2003; 42(4): 781 - 786.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
Z. Wu, C. Maric, D. M. Roesch, W. Zheng, J. G. Verbalis, and K. Sandberg
Estrogen Regulates Adrenal Angiotensin AT1 Receptors by Modulating AT1 Receptor Translation
Endocrinology, July 1, 2003; 144(7): 3251 - 3261.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
Z. Wu, W. Zheng, and K. Sandberg
Estrogen Regulates Adrenal Angiotensin Type 1 Receptors by Modulating Adrenal Angiotensin Levels
Endocrinology, April 1, 2003; 144(4): 1350 - 1356.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
R. Dash, A. G Schmidt, A. Pathak, M. J Gerst, D. Biniakiewicz, V. J Kadambi, B. D Hoit, W. T Abraham, and E. G Kranias
Differential regulation of p38 mitogen-activated protein kinase mediates gender-dependent catecholamine-induced hypertrophy
Cardiovasc Res, March 1, 2003; 57(3): 704 - 714.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
I. Armando, M. Jezova, A. V. Juorio, J. A. Terron, A. Falcon-Neri, C. Semino-Mora, H. Imboden, and J. M. Saavedra
Estrogen upregulates renal angiotensin II AT2 receptors
Am J Physiol Renal Physiol, November 1, 2002; 283(5): F934 - F943.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
M. Fischer, A. Baessler, and H. Schunkert
Renin angiotensin system and gender differences in the cardiovascular system
Cardiovasc Res, February 15, 2002; 53(3): 672 - 677.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society